Final answer:
Omalizumab, or anti-IgE antibodies, effectively treat conditions like asthma and chronic idiopathic urticaria by binding to IgE antibodies and reducing the release of allergic mediators. This treatment is given as a subcutaneous injection and has shown positive results in improving symptoms and reducing the need for other medications.
Step-by-step explanation:
Omalizumab, also known as anti-IgE antibodies, is effective in treating allergic conditions like asthma and chronic idiopathic urticaria. It works by binding to IgE antibodies in the blood and preventing them from attaching to mast cells, thus reducing the release of allergic mediators. This treatment is given as a subcutaneous injection and has been shown to improve symptoms and reduce the need for other medications.